Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

The Rise of Mid-Sized Pharma

Published by: Biopharm Knowledge Publishing

Published: May. 23, 2008 - 117 Pages


Table of Contents


Chapter 1: Introduction

1.1 Investors Cotton On

1.2 New Competition

1.3 A Paternalistic Industry

1.4 Getting in Shape

1.5 New Business Models

1.6 The String of Pearls

1.7 References

Chapter 2: What is Middle Pharma?

2.1 2007 Mid Pharma

2.2 2007 US Mid Pharma Sales Growth

2.2.1 2007 Europe Mid Pharma Sales Growth

2.2.2 2007 Japan Mid Pharma Sales Growth

2.3 Tables Ranked by 2007 Sales Revenues Comparing Big & Middle Pharma Totals

2.3.1 Big Pharma Financials - Revenues

2.3.2 Big Pharma Financials - Net Income

2.3.3 Big Pharma Financials - Price Earnings Ratio

2.3.4 Big Pharma Financials - Market Capitalisation

2.3.5 Mid Pharma Financials - Revenues

2.3.6 Mid Pharma Financials - Net Income

2.3.7 Mid Pharma Financials - Price Earning Ratio

2.3.8 Mid Pharma Financials - Market Capitalisation

2.4 Enormous Diversity

2.5 A Question of Scale

2.6 A Question of Focus

2.7 A Question of Efficiency

2.8 Big & Middle Pharma Tables Ranked by 2007 Sales Revenues

2.8.1 2000-2006 Mid Pharma SG&A

2.8.2 2000-2006 Mid Pharma R&D

2.8.3 2000-2006 Mid Pharma Employees

2.8.4 2000-2006 Big Pharma SG&A

2.8.5 2000-2006 Big Pharma R&D

2.8.6 2000-2006 Big Pharma Employees

2.9 The Japanese Companies

2.10 A Great Place to Work

2.11 References

Chapter 3: A Matter of Scale

3.1 The Value of a Good Reputation

3.1 Big Pharma US Sales as a % of Group Sales

3.1.1 Mid Pharma US Sales as a % of Group Sales

3.2 The Consumer Voice

3.3 A Global Trend

3.4 Increased Regulation

3.5 Critical Path Initiative

3.6 New Regulatory Controls

3.7 A Matter of Scale

3.8 Collaboration, Collaboration, Collaboration

3.9 References

Chapter 4: Reinvention of the Titans

4.1 A Tipping Point

4.2 Downsizing of the Titans

4.2.1 Announced Job Cuts in the Drug Industry (2000-2007)

4.2.2 Announced Job Cuts at Top 15 Companies

4.3 Jostling for Position

4.4 The Challenge of Change

4.5 Sales & Marketing

4.6 Big, Not Necessarily Bad

4.7 References

Chapter 5: Getting the Business Model Right

5.1 Thinking Small Gets Results

5.2 Who Says Elephants Can’t Dance?

5.3 Focus on the Titans

5.4 Greater Collaboration

5.5 The Influence of Private Equity

5.6 Which Business Model Works Best?

5.7 Johnson & Johnson

5.8 The Private Equity Perspective

5.9 References

Chapter 6: Innovation, Innovation, Innovation

6.1 Science as a Leveller

6.2 A Collaborative Future

6.3 Fitness for Purpose

6.4 Niche Markets

6.5 Convergence

6.6 The Patient Voice

6.7 Walking Tall

6.8 References




List of EvaluatePharma Tables

Table 1.1: Top 10 Drugs by US Sales, 2007 in Cardiovascular and CNS Therapeutic Categories

Table 1.2: FDA Approvals (1997-2007)

Table 1.3: US Pharma Sales (2001-2007)

Table 1.4: Cash Flows in Big Pharma

Table 2.1 2007 Mid Pharma

Table 2.2 2007 US Mid Pharma Sales Growth

Table 2.2.1 2007 Europe Mid Pharma Sales Growth

Table 2.2.2 2007 Japan Mid Pharma Sales Growth

Table 2.3 Tables Ranked by 2007 Sales Revenues Comparing Big & Middle Pharma Totals

Table 2.3.1 Big Pharma Financials - Revenues

Table 2.3.2 Big Pharma Financials - Net Income

Table 2.3.3 Big Pharma Financials - Price Earnings Ratio

Table 2.3.4 Big Pharma Financials - Market Capitalisation

Table 2.3.5 Mid Pharma Financials - Revenues

Table 2.3.6 Mid Pharma Financials - Net Income

Table 2.3.7 Mid Pharma Financials - Price Earning Ratio

Table 2.3.8 Mid Pharma Financials - Market Capitalisation

Table 2.4 Specialty Pharma

Table 2.5 Mid-Tier Therapy Focus 2006 (excluding Japanese and Generics companies)

Table 2.8.1 2000-2006 Mid Pharma SG&A

Table 2.8.2 2000-2006 Mid Pharma R&D

Table 2.8.3 2000-2006 Mid Pharma Employees

Table 2.8.4 2000-2006 Big Pharma SG&A

Table 2.8.5 2000-2006 Big Pharma R&D

Table 2.8.6 2000-2006 Big Pharma Employees

Table 3.1: Big Pharma US Sales as a % of Group Sales

Table 3.1.1 Mid Pharma US Sales as a % of Group Sales

Table 4.2.1 Announced Job Cuts in the Drug Industry (2000-2007)

Table 4.2.2 Announced Job Cuts at Top 15 Companies

Abstract

What makes mid-sized companies successful - and what big Pharma can learn from them?

Mid-sized Pharma companies are now much more successful than their bigger rivals - they are growing faster, are more profitable and are performing much better on the world’s stock markets. The reasons behind that success are key to a full understanding of the pharmaceutical industry - and to its future growth.

This new report, published by Biopharm Knowledge Publishing with information from EvaluatePharma®, contains more than 20 detailed tables of Evaluate data and analysis. And it has contributions from Jo Pisani of PwC and Mike Ward, analyst at Nomura Code.

The report makes an in-depth, challenging assessment of the state of the pharmaceutical industry, looking at issues including:
  • The failure of the blockbuster model
  • R&D productivity
  • Therapy Focus
  • Specialist markets
  • Informed consumers
  • The cost of drugs
  • Tougher regulation
  • Drug withdrawals
This report is essential reading for anyone in the biotech, pharmaceutical and clinical outsourcing industries from corporate management through development and research to marketing and sales. It gives an authoritative, detailed and clear explanation of the issues surrounding mid-sized pharma and their implications for the market and for the biotech and pharmaceutical industries.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008